Table 3 Additional variants from sequential rounds of conditioning.
Phenotype (primary variant) | Round | Variant | hg19 chr 6 position | Distance (bp) from primary variant^ | p | pcorr* |
|---|---|---|---|---|---|---|
ADA positive (AA_DRB1_120_32657518_N) | ||||||
1 | rs3093664 | 31544641 | 1004898 | 1.16E−06 | < 0.001 | |
2 | rs3130215 | 31525911 | 1023628 | 2.54E−06 | < 0.001 | |
3 | rs9268500 | 32376516 | 173023 | 5.46E−06 | < 0.001 | |
4 | rs9268543 | 32384800 | 164739 | 1.11E−08 | < 0.001 | |
5 | rs9469069 | 31866417 | 683122 | 4.64E−05 | < 0.001 | |
6 | rs3763313 | 32376470 | 173069 | 1.49E−04 | 0.001 | |
7 | rs3130062 | 31525911 | 1023628 | 1.01E−03 | 0.006 | |
8 | rs29220 | 29589665 | 2959874 | 1.08E−03 | 0.010 | |
9 | rs2267635 | 29592430 | 2957109 | 5.86E−04 | 0.013 | |
10 | rs4713420 | 30993566 | 1555973 | 2.40E−03 | 0.029 | |
ADA max titer (rs7756741) | ||||||
1 | AA_DRB1_13_32660109_FG | 32552130 | 31067 | 4.69E−05 | 0.002 | |
2 | rs2523453 | 31368124 | 1215073 | 1.49E−05 | 0.002 | |
3 | rs17496549 | 32409707 | 173490 | 4.92E−04 | 0.007 | |
4 | AA_C_9_31347600_S | 31239620 | 1343577 | 9.42E−04 | 0.015 | |
5 | rs2240804 | 30920889 | 1662308 | 1.93E−03 | 0.041 | |
6 | rs3763355 | 32786881 | − 203684 | 2.48E−03 | 0.056 | |
7 | rs2395171 | 32394536 | 188661 | 3.01E−03 | 0.093 | |